Last updated on January 2019

Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study


Brief description of study

This study will provide continuing availability to tazemetostat as a single agent to subjects who have completed their participation in an antecedent tazemetostat study (either with monotherapy or combination therapy). In addition, long-term safety and overall survival will be collected.

Clinical Study Identifier: NCT02875548

Find a site near you

Start Over

Epizyme

East Melbourne, Australia
2.97miles
  Connect »